首页 > 最新文献

Innovations in Pharmacy最新文献

英文 中文
Some People are Different from You: A Case Study of a Cultural and Ethical Problem in Global Health. 有些人与你不同:全球健康中的文化和伦理问题的个案研究。
Pub Date : 2022-01-01 DOI: 10.24926/iip.v13i2.4919
John Rovers, Erin Ulrich

Pharmacists, student pharmacists, and other healthcare providers are frequent participants on short-term medical service trips (MSTs) to medically underserved areas. Many such MSTs take place in areas like sub-Saharan Africa where cultural beliefs about healthcare and society may be very different from what volunteers from the Global North believe. These cultural divergences may then give rise to ethical problems MST volunteers need to navigate. This case study provides an example of such an ethical problem developing from a difference in cultures - the case of female genital cutting. Often, the ethical training that most MST volunteers receive during their clinical education is inadequate to help them address these kinds of cultural differences and the problems that result. A six-step process to provide MST volunteers with the tools to address such cultural-ethical problems is included. Medical, Public Health, and Microfinance Teams with local interpreters in Nana Kenieba, Cercle of Kati, Koulikoro Region, Southwest Mali.

药剂师、学生药剂师和其他医疗保健提供者经常参加短期医疗服务旅行(MSTs),前往医疗服务不足的地区。许多此类mst发生在撒哈拉以南非洲等地区,这些地区关于医疗保健和社会的文化信仰可能与全球北方志愿者的信仰大不相同。这些文化差异可能会引发MST志愿者需要解决的伦理问题。这个案例研究提供了这样一个伦理问题从文化差异发展的例子-女性生殖器切割的情况。通常,大多数MST志愿者在临床教育期间接受的道德培训不足以帮助他们解决这些文化差异和由此产生的问题。其中包括为MST志愿者提供解决这些文化伦理问题的工具的六个步骤。医疗、公共卫生和小额信贷小组与当地口译人员在马里西南部库利科罗地区卡蒂区娜娜·肯内巴工作。
{"title":"Some People are Different from You: A Case Study of a Cultural and Ethical Problem in Global Health.","authors":"John Rovers,&nbsp;Erin Ulrich","doi":"10.24926/iip.v13i2.4919","DOIUrl":"https://doi.org/10.24926/iip.v13i2.4919","url":null,"abstract":"<p><p>Pharmacists, student pharmacists, and other healthcare providers are frequent participants on short-term medical service trips (MSTs) to medically underserved areas. Many such MSTs take place in areas like sub-Saharan Africa where cultural beliefs about healthcare and society may be very different from what volunteers from the Global North believe. These cultural divergences may then give rise to ethical problems MST volunteers need to navigate. This case study provides an example of such an ethical problem developing from a difference in cultures - the case of female genital cutting. Often, the ethical training that most MST volunteers receive during their clinical education is inadequate to help them address these kinds of cultural differences and the problems that result. A six-step process to provide MST volunteers with the tools to address such cultural-ethical problems is included. Medical, Public Health, and Microfinance Teams with local interpreters in Nana Kenieba, Cercle of Kati, Koulikoro Region, Southwest Mali.</p>","PeriodicalId":13646,"journal":{"name":"Innovations in Pharmacy","volume":"13 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/26/a6/21550417-13-02-4919.PMC9836763.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10550461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phenytoin Toxicity with High Dose, Concomitant Ascorbic Acid Dosing. 大剂量苯妥英毒性,同时服用抗坏血酸。
Pub Date : 2022-01-01 DOI: 10.24926/iip.v13i4.5122
Michael J Schuh, Kevin Mustain, Sheena Crosby

High dose ascorbic acid may increase risk of phenytoin toxicity. This case report demonstrates high phenytoin levels resulting in adverse drug reactions subsequent to dosing concomitantly with high dose vitamin C, or ascorbic acid (AA), as a precaution against acquiring corona virus (COVID) infection. This patient suffered from a major seizure when he ran out of his phenytoin prescription. Subsequent initiation of phenytoin and later addition of high dose AA resulted in truncal ataxia and falls with bilateral wrist and finger extension weakness. Phenytoin and AA were discontinued, and the patient returned to baseline on a new medication regimen of lacosamide and gabapentin without any other major seizures one year later.

大剂量抗坏血酸可能增加苯妥英中毒的风险。本病例报告显示,作为预防感染冠状病毒(COVID)的预防措施,与高剂量维生素C或抗坏血酸(AA)同时服用时,苯妥英水平高会导致药物不良反应。这个病人在苯妥英处方用完后发生了严重的癫痫发作。随后开始使用苯妥英和后来添加高剂量AA导致躯干共济失调和跌倒,双侧手腕和手指伸展无力。停用苯妥英和AA,患者在一年后恢复到基线,使用拉科沙胺和加巴喷丁的新药物治疗方案,没有任何其他主要癫痫发作。
{"title":"Phenytoin Toxicity with High Dose, Concomitant Ascorbic Acid Dosing.","authors":"Michael J Schuh,&nbsp;Kevin Mustain,&nbsp;Sheena Crosby","doi":"10.24926/iip.v13i4.5122","DOIUrl":"https://doi.org/10.24926/iip.v13i4.5122","url":null,"abstract":"<p><p>High dose ascorbic acid may increase risk of phenytoin toxicity. This case report demonstrates high phenytoin levels resulting in adverse drug reactions subsequent to dosing concomitantly with high dose vitamin C, or ascorbic acid (AA), as a precaution against acquiring corona virus (COVID) infection. This patient suffered from a major seizure when he ran out of his phenytoin prescription. Subsequent initiation of phenytoin and later addition of high dose AA resulted in truncal ataxia and falls with bilateral wrist and finger extension weakness. Phenytoin and AA were discontinued, and the patient returned to baseline on a new medication regimen of lacosamide and gabapentin without any other major seizures one year later.</p>","PeriodicalId":13646,"journal":{"name":"Innovations in Pharmacy","volume":"13 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256283/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9620467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Burnout and Resilience in the Community-Based Pharmacist Practitioner. 以社区为基础的药剂师从业人员的职业倦怠和恢复力。
Pub Date : 2022-01-01 DOI: 10.24926/iip.v13i4.4818
Kristine M Cline, Bella Mehta

Objective: The primary objective was to assess presence of community-based pharmacist practitioner burnout and workplace stress through administration of validated tools. Methods: Pharmacists licensed in Ohio received an invitation to participate in the anonymous online assessment via Qualtrics™ using emails available via the State Board of Pharmacy listserv. The survey assessed emotional exhaustion, depersonalization, and personal accomplishment using a validated tool, the Maslach Burnout Inventory (MBI). The Areas of Worklife Survey (AWS) was used to assess stressors as they relate to burnout and job stress. This study was approved by The Ohio State University Institutional Review Board. Results: There were 1,425 complete responses. Based on the study sample, 67.2% of community-based pharmacists are experiencing burnout. When asked to self-identify workplace stressors, respondents primarily described the Workload, Control, and Reward dimensions of the AWS. The most commonly reported coping mechanisms were self-care strategies (28.4%), mindfulness (17.6%), and personal time/time off (15.3%). Respondents suggested that organizations address staffing (50.2%) and development of a culture of well-being (17.2%) to promote well-being. Conclusion: This study allowed insight into workplace stressors for community-based pharmacists and strategies organizations can employ to improve their well-being. Future studies are needed to assess the efficacy of these interventions.

目的:主要目的是通过管理有效的工具来评估社区执业药师职业倦怠和工作压力的存在。方法:在俄亥俄州获得许可的药剂师收到了通过Qualtrics™匿名在线评估的邀请,该邀请使用的电子邮件可通过州药学委员会listserv获得。该调查使用一种经过验证的工具——马斯拉克倦怠量表(MBI)来评估情绪衰竭、人格解体和个人成就。工作生活领域调查(AWS)用于评估压力源,因为它们与倦怠和工作压力有关。这项研究得到了俄亥俄州立大学机构审查委员会的批准。结果:完整应答1425例。根据研究样本,67.2%的社区药师存在职业倦怠。当被要求自我识别工作场所压力源时,受访者主要描述了AWS的工作量、控制和奖励维度。最常见的应对机制是自我照顾策略(28.4%)、正念(17.6%)和个人时间/休假(15.3%)。受访者建议,组织应解决人员配备(50.2%)和发展幸福文化(17.2%)的问题,以促进幸福。结论:本研究允许深入了解社区药剂师的工作压力源和组织可以采用的策略来改善他们的幸福感。需要进一步的研究来评估这些干预措施的有效性。
{"title":"Burnout and Resilience in the Community-Based Pharmacist Practitioner.","authors":"Kristine M Cline,&nbsp;Bella Mehta","doi":"10.24926/iip.v13i4.4818","DOIUrl":"https://doi.org/10.24926/iip.v13i4.4818","url":null,"abstract":"<p><p><b>Objective:</b> The primary objective was to assess presence of community-based pharmacist practitioner burnout and workplace stress through administration of validated tools. <b>Methods:</b> Pharmacists licensed in Ohio received an invitation to participate in the anonymous online assessment via Qualtrics™ using emails available via the State Board of Pharmacy listserv. The survey assessed emotional exhaustion, depersonalization, and personal accomplishment using a validated tool, the Maslach Burnout Inventory (MBI). The Areas of Worklife Survey (AWS) was used to assess stressors as they relate to burnout and job stress. This study was approved by The Ohio State University Institutional Review Board. <b>Results:</b> There were 1,425 complete responses. Based on the study sample, 67.2% of community-based pharmacists are experiencing burnout. When asked to self-identify workplace stressors, respondents primarily described the Workload, Control, and Reward dimensions of the AWS. The most commonly reported coping mechanisms were self-care strategies (28.4%), mindfulness (17.6%), and personal time/time off (15.3%). Respondents suggested that organizations address staffing (50.2%) and development of a culture of well-being (17.2%) to promote well-being. <b>Conclusion:</b> This study allowed insight into workplace stressors for community-based pharmacists and strategies organizations can employ to improve their well-being. Future studies are needed to assess the efficacy of these interventions.</p>","PeriodicalId":13646,"journal":{"name":"Innovations in Pharmacy","volume":"13 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256298/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9621749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conversion Disorder in a Pharmacogenomics, Polypharmacy Patient: Case Report. 转换障碍的药物基因组学,多药患者:病例报告。
Pub Date : 2021-09-22 eCollection Date: 2021-01-01 DOI: 10.24926/iip.v12i4.4034
Michael J Schuh, Sheena Crosby

Background: Conversion disorder (CD) is a relatively common psychiatric disorder likely encountered by clinical pharmacists but probably not easily identified by pharmacists. Case Summary: This is a patient case where a patient with a tremor was referred to the pharmacist led, polypharmacy, pharmacogenomics (PGx) service to rule out a PGx cause due to medication metabolism. No pharmacologic or PGx cause was found for the tremor which helped support and confirm a diagnosis of CD. Practice Implications: By working collaboratively with psychiatrists, neurologists, physical medicine colleagues, clinical pharmacists may add value to patient care by assisting with diagnoses and appropriate treatment.

背景:转化障碍(Conversion disorder, CD)是一种比较常见的精神障碍,临床药师可能会遇到,但可能不容易被药剂师识别。病例总结:这是一个患者病例,震颤患者被推荐到药剂师领导的综合药学药物基因组学(PGx)服务,以排除由于药物代谢引起的PGx原因。没有发现震颤的药理学或PGx原因,这有助于支持和确认乳糜泻的诊断。实践意义:通过与精神科医生、神经科医生、物理医学同事合作,临床药剂师可以通过协助诊断和适当治疗来增加患者护理的价值。
{"title":"Conversion Disorder in a Pharmacogenomics, Polypharmacy Patient: Case Report.","authors":"Michael J Schuh,&nbsp;Sheena Crosby","doi":"10.24926/iip.v12i4.4034","DOIUrl":"https://doi.org/10.24926/iip.v12i4.4034","url":null,"abstract":"<p><p><b>Background:</b> Conversion disorder (CD) is a relatively common psychiatric disorder likely encountered by clinical pharmacists but probably not easily identified by pharmacists. <b>Case Summary:</b> This is a patient case where a patient with a tremor was referred to the pharmacist led, polypharmacy, pharmacogenomics (PGx) service to rule out a PGx cause due to medication metabolism. No pharmacologic or PGx cause was found for the tremor which helped support and confirm a diagnosis of CD. <b>Practice Implications:</b> By working collaboratively with psychiatrists, neurologists, physical medicine colleagues, clinical pharmacists may add value to patient care by assisting with diagnoses and appropriate treatment.</p>","PeriodicalId":13646,"journal":{"name":"Innovations in Pharmacy","volume":"12 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/94/70/21550417-12-04-4034.PMC9401363.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33442579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Pharmacogenomics Testing Confirmation of Carbamazepine Induced DRESS Reaction of an HLA-A*31:01 Positive, Polypharmacy Patient. 卡马西平诱导HLA-A*31:01阳性多药患者DRESS反应的药物基因组学检测
Pub Date : 2021-09-22 eCollection Date: 2021-01-01 DOI: 10.24926/iip.v12i4.4341
Leigh Speicher, Sheena Crosby, Michael J Schuh

Pharmacogenomics (PGx) melds well with polypharmacy as another tool to identify medication related problems (MRPs) more specifically so they may be solved most effectively. PGx can pre-emptively assist in medication selection, medication dosing or identify better medications for patients already taking a medication. PGx can also confirm suspect medications of causing MRPs such as adverse drug reactions (ADRs) or drug interactions. In this case, PGx testing confirmed presence of a serious human leukocyte antigen (HLA) drug reaction with eosinophilia and systemic symptoms (DRESS) after a suspect medication had been stopped.

药物基因组学(PGx)与多药学(polypharmacy)很好地融合在一起,作为更具体地识别药物相关问题(mrp)的另一种工具,从而可以最有效地解决这些问题。PGx可以预先协助药物选择,药物剂量或为已经服用药物的患者确定更好的药物。PGx还可以确认引起mrp的可疑药物,如药物不良反应(adr)或药物相互作用。在该病例中,PGx检测证实在疑似停药后存在严重的人白细胞抗原(HLA)药物反应,伴嗜酸性粒细胞增多和全身症状(DRESS)。
{"title":"Pharmacogenomics Testing Confirmation of Carbamazepine Induced DRESS Reaction of an HLA-A*31:01 Positive, Polypharmacy Patient.","authors":"Leigh Speicher,&nbsp;Sheena Crosby,&nbsp;Michael J Schuh","doi":"10.24926/iip.v12i4.4341","DOIUrl":"https://doi.org/10.24926/iip.v12i4.4341","url":null,"abstract":"<p><p>Pharmacogenomics (PGx) melds well with polypharmacy as another tool to identify medication related problems (MRPs) more specifically so they may be solved most effectively. PGx can pre-emptively assist in medication selection, medication dosing or identify better medications for patients already taking a medication. PGx can also confirm suspect medications of causing MRPs such as adverse drug reactions (ADRs) or drug interactions. In this case, PGx testing confirmed presence of a serious human leukocyte antigen (HLA) drug reaction with eosinophilia and systemic symptoms (DRESS) after a suspect medication had been stopped.</p>","PeriodicalId":13646,"journal":{"name":"Innovations in Pharmacy","volume":"12 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0b/75/21550417-12-04-4341.PMC9401381.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33442581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Evaluation of an Interprofessional Academic-Practice Partnership in End of Life Care. 临终关怀中跨专业学术与实践伙伴关系的评估。
Pub Date : 2021-09-22 eCollection Date: 2021-01-01 DOI: 10.24926/iip.v12i4.4004
Katie F Leslie, M Kate Probst, Taylor L Hawkins

Introduction: The purpose of this mixed-methods study was to evaluate an interprofessional academic-practice partnership in end of life care by examining patient medication outcomes, the contributions of student pharmacists and a pharmacy preceptor to care teams, and student learning experiences. Methods: Retrospective chart review assessed polypharmacy differences in hospice patients with a primary terminal diagnosis of non-Alzheimer's dementia between two patient groups; Group 1 managed on interprofessional care teams within the pharmacy partnership, and Group 2, managed on teams without a pharmacist. Team members who interacted with student pharmacists and the pharmacy preceptor participated in semi-structured key informant interviews to document perceptions of pharmacy contributions to care teams and the organization. At the end of their APPE, students completed reflective writings regarding their learning. Results: Patients in Group 1 were on statistically significant fewer medications than Group 2 at both week 4 and weeks 7-12 following admission. Five conceptual themes emerged from interviews: pharmacists as team medication experts, improved patient outcomes, interprofessional collaboration, patient/caregiver trust in medication regimens, and desire for sustainability. Student reflections included the following learning themes: teamwork, respect, value, and patient-centered care. Conclusions: The addition of a pharmacist on interprofessional care teams decreased the average number of medications in the non-Alzheimer's end of life patient population. Team members identified value-added contributions of student pharmacists and the pharmacy preceptor that enhanced team efficiency and patient care. Student pharmacists recognized these contributions and the experience served as an exemplar of interprofessional practice.

引言:这项混合方法研究的目的是通过检查患者的药物治疗结果、学生药剂师和药学导师对护理团队的贡献以及学生的学习经历,来评估临终关怀中的跨专业学术实践伙伴关系。方法:回顾性图表回顾评估了两组患者中以非阿尔茨海默氏痴呆为主要终末期诊断的临终关怀患者的多药治疗差异;第1组由药房合作伙伴关系内的跨专业护理团队管理,第2组由没有药剂师的团队管理。与学生药剂师和药学导师互动的团队成员参加了半结构化的关键信息员访谈,以记录对护理团队和组织的药学贡献的看法。在APPE结束时,学生们完成了关于他们学习的反思性写作。结果:在入院后第4周和第7-12周,第1组患者服用的药物比第2组少,具有统计学意义。访谈中出现了五个概念主题:药剂师作为团队药物专家,改善患者结果,跨专业合作,患者/护理人员对药物方案的信任,以及对可持续性的渴望。学生的反思包括以下学习主题:团队合作、尊重、价值观和以患者为中心的护理。结论:在跨专业护理团队中增加一名药剂师,降低了非阿尔茨海默氏症临终患者群体的平均药物数量。团队成员确定了学生药剂师和药学导师的增值贡献,这些贡献提高了团队效率和患者护理。学生药剂师认可了这些贡献,他们的经验成为跨专业实践的典范。
{"title":"Evaluation of an Interprofessional Academic-Practice Partnership in End of Life Care.","authors":"Katie F Leslie, M Kate Probst, Taylor L Hawkins","doi":"10.24926/iip.v12i4.4004","DOIUrl":"10.24926/iip.v12i4.4004","url":null,"abstract":"<p><p><b>Introduction:</b> The purpose of this mixed-methods study was to evaluate an interprofessional academic-practice partnership in end of life care by examining patient medication outcomes, the contributions of student pharmacists and a pharmacy preceptor to care teams, and student learning experiences. <b>Methods:</b> Retrospective chart review assessed polypharmacy differences in hospice patients with a primary terminal diagnosis of non-Alzheimer's dementia between two patient groups; Group 1 managed on interprofessional care teams within the pharmacy partnership, and Group 2, managed on teams without a pharmacist. Team members who interacted with student pharmacists and the pharmacy preceptor participated in semi-structured key informant interviews to document perceptions of pharmacy contributions to care teams and the organization. At the end of their APPE, students completed reflective writings regarding their learning. <b>Results:</b> Patients in Group 1 were on statistically significant fewer medications than Group 2 at both week 4 and weeks 7-12 following admission. Five conceptual themes emerged from interviews: pharmacists as team medication experts, improved patient outcomes, interprofessional collaboration, patient/caregiver trust in medication regimens, and desire for sustainability. Student reflections included the following learning themes: teamwork, respect, value, and patient-centered care. <b>Conclusions:</b> The addition of a pharmacist on interprofessional care teams decreased the average number of medications in the non-Alzheimer's end of life patient population. Team members identified value-added contributions of student pharmacists and the pharmacy preceptor that enhanced team efficiency and patient care. Student pharmacists recognized these contributions and the experience served as an exemplar of interprofessional practice.</p>","PeriodicalId":13646,"journal":{"name":"Innovations in Pharmacy","volume":"12 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0e/88/21550417-12-04-4004.PMC9401366.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33442495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Why Nigeria Must Strengthen its Local Pharmaceutical Manufacturing Capacity. 为什么尼日利亚必须加强其本地药品生产能力。
Pub Date : 2021-09-22 eCollection Date: 2021-01-01 DOI: 10.24926/iip.v12i4.4208
Melody Okereke, Adebowale Adekunbi, Yusuf Ghazali

With over 115 registered pharmaceutical manufacturers, Nigeria still depends on other countries for the supply of active pharmaceutical ingredients and excipients. Significant attention has not been paid to the local production of raw materials, pharmaceutical dosage formulations, or processing equipment, which has resulted in a decline in the country's pharmaceutical manufacturing capacity. Owing to the overall importance of the pharmaceutical industry, it is, therefore, essential to pay close attention to developmental issues affecting this sector. In this commentary, we explore why Nigeria must boost its local pharmaceutical manufacturing capacity.

尼日利亚有超过115家注册药品制造商,仍然依赖其他国家供应活性药物成分和赋形剂。对当地生产的原料、药物剂型或加工设备没有给予足够的重视,这导致了该国药品生产能力的下降。由于制药业的总体重要性,因此必须密切注意影响这一部门的发展问题。在这篇评论中,我们探讨了尼日利亚为什么必须提高其当地的药品制造能力。
{"title":"Why Nigeria Must Strengthen its Local Pharmaceutical Manufacturing Capacity.","authors":"Melody Okereke,&nbsp;Adebowale Adekunbi,&nbsp;Yusuf Ghazali","doi":"10.24926/iip.v12i4.4208","DOIUrl":"https://doi.org/10.24926/iip.v12i4.4208","url":null,"abstract":"<p><p>With over 115 registered pharmaceutical manufacturers, Nigeria still depends on other countries for the supply of active pharmaceutical ingredients and excipients. Significant attention has not been paid to the local production of raw materials, pharmaceutical dosage formulations, or processing equipment, which has resulted in a decline in the country's pharmaceutical manufacturing capacity. Owing to the overall importance of the pharmaceutical industry, it is, therefore, essential to pay close attention to developmental issues affecting this sector. In this commentary, we explore why Nigeria must boost its local pharmaceutical manufacturing capacity.</p>","PeriodicalId":13646,"journal":{"name":"Innovations in Pharmacy","volume":"12 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/65/a2/21550417-12-04-4208.PMC9401367.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33442493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
A Critical Examination of Simulation Pricing and Access Recommendations for Atopic Dermatitis. 特应性皮炎的模拟定价和准入建议的关键检查。
Pub Date : 2021-09-22 eCollection Date: 2021-01-01 DOI: 10.24926/iip.v12i4.4329
Paul C Langley

It has been demonstrated conclusively that value and utility preference scores have only ordinal properties. This means, as has been pointed out on numerous occasions, that the quality adjusted life year (QALY) is a mathematically impossible construct. The implications are profound: Some 30 years of health technology assessment is called into question due to a failure to recognize the well-documented limitations imposed by the axioms of fundamental measurement. The purpose of this commentary is provide a critical examination of this practice in recommendations for atopic dermatitis.

结论表明,价值偏好得分和效用偏好得分仅具有序数性质。这意味着,正如在许多场合指出的那样,质量调整生命年(QALY)在数学上是不可能的结构。其影响是深远的:由于未能认识到基本测量公理所施加的充分证明的限制,大约30年的卫生技术评估受到质疑。本评论的目的是为特应性皮炎的建议提供这种做法的关键检查。
{"title":"A Critical Examination of Simulation Pricing and Access Recommendations for Atopic Dermatitis.","authors":"Paul C Langley","doi":"10.24926/iip.v12i4.4329","DOIUrl":"https://doi.org/10.24926/iip.v12i4.4329","url":null,"abstract":"<p><p>It has been demonstrated conclusively that value and utility preference scores have only ordinal properties. This means, as has been pointed out on numerous occasions, that the quality adjusted life year (QALY) is a mathematically impossible construct. The implications are profound: Some 30 years of health technology assessment is called into question due to a failure to recognize the well-documented limitations imposed by the axioms of fundamental measurement. The purpose of this commentary is provide a critical examination of this practice in recommendations for atopic dermatitis.</p>","PeriodicalId":13646,"journal":{"name":"Innovations in Pharmacy","volume":"12 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1f/d7/21550417-12-04-4329.PMC9401380.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33442577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Pharmacist in Disaster Management: A Quantitative Content Analysis Approach. 药师在灾害管理中的作用:定量内容分析方法。
Pub Date : 2021-09-22 eCollection Date: 2021-01-01 DOI: 10.24926/iip.v12i4.4359
Muhammad Ahmer Raza, Shireen Aziz, Misbah Noreen, Shahid Masood Raza

Background: Little attention has been given to characterizing the roles of pharmacists in disasters even though the importance of pharmacists' involvement is widely acknowledged. Objective: We amid to review a broad range of pharmacists roles in disasters and their response by numerous reports in the literature. Method: A quantitative content analysis technique was used to gather data consisting of words and phrases from literature regarding pharmacists' roles and their response in disasters. Results: A total of 106 reports were reviewed and screened based on titles and abstracts. Of these, only 20 studies were determined to meet the eligibility criteria for discussion. A total of 7 natural disasters (pandemics, tornadoes, fires, earthquakes, floods, hurricanes and storms) were found in the literature. Roles were classified using the Setlak classification scheme, which includes descriptors such as pharmaceutical supply, patient management, policy coordination, and response integration. Pharmaceutical supply was remains the pharmacists' preferred role. Conclusion: It is evident from the literature that pharmacists are uniquely positioned during disasters to provide healthcare continuity and medication.

背景:很少有人关注的特点,药剂师在灾害中的作用,即使药剂师的参与的重要性是公认的。目的:我们希望通过文献中的大量报道来回顾药剂师在灾难中的广泛作用和他们的反应。方法:采用定量内容分析技术,从文献中收集有关药师在灾害中的作用及应对的相关词汇和短语。结果:根据题目和摘要对106份报告进行了审查和筛选。其中,只有20项研究被确定符合讨论的资格标准。文献中共发现了7种自然灾害(流行病、龙卷风、火灾、地震、洪水、飓风和风暴)。使用Setlak分类方案对角色进行分类,其中包括诸如药品供应、患者管理、政策协调和响应集成等描述符。药品供应仍然是药剂师的首选角色。结论:从文献中可以明显看出,在灾害中,药剂师在提供医疗连续性和药物治疗方面具有独特的地位。
{"title":"Role of Pharmacist in Disaster Management: A Quantitative Content Analysis Approach.","authors":"Muhammad Ahmer Raza,&nbsp;Shireen Aziz,&nbsp;Misbah Noreen,&nbsp;Shahid Masood Raza","doi":"10.24926/iip.v12i4.4359","DOIUrl":"https://doi.org/10.24926/iip.v12i4.4359","url":null,"abstract":"<p><p><b>Background:</b> Little attention has been given to characterizing the roles of pharmacists in disasters even though the importance of pharmacists' involvement is widely acknowledged. <b>Objective:</b> We amid to review a broad range of pharmacists roles in disasters and their response by numerous reports in the literature. <b>Method:</b> A quantitative content analysis technique was used to gather data consisting of words and phrases from literature regarding pharmacists' roles and their response in disasters. <b>Results:</b> A total of 106 reports were reviewed and screened based on titles and abstracts. Of these, only 20 studies were determined to meet the eligibility criteria for discussion. A total of 7 natural disasters (pandemics, tornadoes, fires, earthquakes, floods, hurricanes and storms) were found in the literature. Roles were classified using the Setlak classification scheme, which includes descriptors such as pharmaceutical supply, patient management, policy coordination, and response integration. Pharmaceutical supply was remains the pharmacists' preferred role. <b>Conclusion:</b> It is evident from the literature that pharmacists are uniquely positioned during disasters to provide healthcare continuity and medication.</p>","PeriodicalId":13646,"journal":{"name":"Innovations in Pharmacy","volume":"12 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0d/a7/21550417-12-04-4359.PMC9401375.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33442445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Evaluation of Hospital-Based Acute Care Utilization by Uninsured Patients Enrolled in Free or Low-Cost Pharmacy Programs. 对参加免费或低成本药房计划的无保险患者的医院急性护理利用的评估。
Pub Date : 2021-09-22 eCollection Date: 2021-01-01 DOI: 10.24926/iip.v12i4.3998
Jessica Stickel, Jennifer Kim

Background: Research is warranted to define the role of affordable pharmacy programs in optimizing healthcare utilization for uninsured patients. Methods: This was a pre-post study including uninsured patients from an internal medicine residency clinic who enrolled in free or low-cost pharmacy programs with clinical pharmacist support. Results: In the period following program enrollment (N=116), there was a mean decrease of 0.23 acute care encounters (hospitalizations and emergency department [ED] visits) per patient (p=0.0210, 95% CI 0.04-0.43). The mean decrease for hospitalizations was also statistically significant (0.17, p=0.0052, 95% CI 0.05-0.28), but the mean decrease for ED visits was not (0.06, p=0.3771, 95% CI -0.08-0.21). Using the national average hospitalization cost of $10,700, the decrease in hospitalizations represents an estimated savings of $246,100. Conclusions: Enrollment in affordable pharmacy programs was found to be associated with decreased acute care encounters.

背景:研究是必要的,以确定负担得起的药房计划在优化医疗保健利用为无保险的病人。方法:这是一项前后研究,包括来自内科住院医师诊所的无保险患者,他们在临床药师的支持下注册了免费或低成本的药房项目。结果:在项目入组后的一段时间内(N=116),每位患者平均减少0.23次急症护理(住院和急诊科[ED]就诊)(p=0.0210, 95% CI 0.04-0.43)。住院的平均减少也有统计学意义(0.17,p=0.0052, 95% CI 0.05-0.28),但ED就诊的平均减少没有统计学意义(0.06,p=0.3771, 95% CI -0.08-0.21)。按全国平均住院费用10 700美元计算,住院人数的减少估计节省241 100美元。结论:在可负担得起的药房项目注册被发现与减少急性护理接触有关。
{"title":"Evaluation of Hospital-Based Acute Care Utilization by Uninsured Patients Enrolled in Free or Low-Cost Pharmacy Programs.","authors":"Jessica Stickel,&nbsp;Jennifer Kim","doi":"10.24926/iip.v12i4.3998","DOIUrl":"https://doi.org/10.24926/iip.v12i4.3998","url":null,"abstract":"<p><p><b>Background:</b> Research is warranted to define the role of affordable pharmacy programs in optimizing healthcare utilization for uninsured patients. <b>Methods</b>: This was a pre-post study including uninsured patients from an internal medicine residency clinic who enrolled in free or low-cost pharmacy programs with clinical pharmacist support. <b>Results</b>: In the period following program enrollment (N=116), there was a mean decrease of 0.23 acute care encounters (hospitalizations and emergency department [ED] visits) per patient (p=0.0210, 95% CI 0.04-0.43). The mean decrease for hospitalizations was also statistically significant (0.17, p=0.0052, 95% CI 0.05-0.28), but the mean decrease for ED visits was not (0.06, p=0.3771, 95% CI -0.08-0.21). Using the national average hospitalization cost of $10,700, the decrease in hospitalizations represents an estimated savings of $246,100. <b>Conclusions</b>: Enrollment in affordable pharmacy programs was found to be associated with decreased acute care encounters.</p>","PeriodicalId":13646,"journal":{"name":"Innovations in Pharmacy","volume":"12 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ba/1a/21550417-12-04-3998.PMC9401382.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33442447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Innovations in Pharmacy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1